San Clemente-based VertiFlex Inc. has another $14 million in its coffers as it goes about bringing a medical device for less-invasive treatments of painful spine problems to market. VertiFlex’s main ...
An orthopedic advisory panel voted to approve Vertiflex's PMA application to the FDA for its Superion Interspinous Spacer (ISS), a spinal implant designed to treat moderate lumbar stenosis and pain, ...
VertiFlex is facing a regulatory setback for its spine implant, as the FDA postponed a meeting slated to review the company's application for premarket approval (PMA) of the device. The agency's ...
(May 26, 2015) VertiFlex, Inc., announced that it has been granted pre-market approval by the FDA for its minimally invasive treatment of lumbar spinal stenosis, the Superion Interspinous Spacer ...
VertiFlex earned FDA PMA Approval Order for the Superion Interspinous Spacer System. 1. Earlier this year, the FDA Advisory Panel voted that Superion demonstrated safety and effectiveness and a ...
CARLSBAD, Calif.--(BUSINESS WIRE)--Vertiflex® Inc., a leading innovator of advanced, minimally invasive interventions for spinal stenosis, announced additional results from a randomized, controlled ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. The Orthopaedic and Rehabilitation Devices Panel of the ...
San Clemente-based VertiFlex Inc. said that it has received Food and Drug Administration clearance for two spinal implant devices. VertiFlex makes less-invasive medical devices for treating a range of ...
CARLSBAD, Calif.--(BUSINESS WIRE)--Vertiflex, Inc., a leading innovator of advanced, minimally invasive interventions for spinal stenosis, today announced the appointment of Michael Enxing as Vice ...
SAN CLEMENTE, Calif.– VertiFlex®, Inc., a leading innovator of percutaneous and motion preserving spinal surgery technologies, today announced completion of a $14M equity placement, with provision for ...
San Clemente-based VertiFlex Inc. has raised $15.2 million from six investors, according to filings with the SEC. The company specializes in spinal devices to treat lumbar spinal stenosis, the leading ...
Gormley’s Take: Vertiflex’s Path to Acquisition Shows Opportunities, Hurdles for Orthopedic Startups
The path that led to Boston Scientific Corp.’s acquisition of Vertiflex Inc. illustrates the opportunity for startups with treatments for skeletal disorders—and the challenges that keep many investors ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results